Bischof K, Holth A, Bassarova A, Davidson B(2024) Expression of PRAME in high-grade serous carcinoma is associated with higher residual disease volume and Occludin expression Pathol Res Pract, 266, 155787(in press) DOI 10.1016/j.prp.2024.155787, PubMed 39709875
Mirza MR, Bjørge L, Marmé F, Christensen RD, Gil-Martin M, Auranen A, Ataseven B, Rubio MJ, Salutari V, Luczak AA, Runnebaum IB, Redondo A, Lindemann K, Trillsch F, Ginesta MPB, Roed H, Kurtz JE, Petersson KS, Nyvang GB, Sehouli J(2024) Palbociclib plus letrozole in estrogen receptor-positive advanced/recurrent endometrial cancer: Double-blind placebo-controlled randomized phase II ENGOT-EN3/PALEO trial Gynecol Oncol, 192, 128-136(in press) DOI 10.1016/j.ygyno.2024.12.003, PubMed 39657575
Areklett EW, Hagen BI, Stubberud J, Fagereng E, Andersson S, Lindemann K(2024) Digital goal management training for cognitive impairment in cervical cancer survivors-a randomized comparison study J Cancer Surviv(in press) DOI 10.1007/s11764-024-01701-4, PubMed 39576570